Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Blue Cross NC | Genome and Exome Sequencing AHS – M2032PayerPolicy · BCBSNC-GENOME-AND-EXOME-SEQUENCING-AHS-M2032-67437D983D | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing of Mitochondrial Disorders AHS – M2085PayerPolicy · BCBSNC-GENETIC-TESTING-OF-MITOCHONDRIAL-DISORDERS-AHS-M2085-63A3856AA6 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing of CADASIL Syndrome AHS – M2069PayerPolicy · BCBSNC-GENETIC-TESTING-OF-CADASIL-SYNDROME-AHS-M2069-94020F5781 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Rett Syndrome AHS – M2088PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-RETT-SYNDROME-AHS-M2088-227EE9E302 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for PTEN Hamartoma Tumor Syndrome AHS – M2087PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-PTEN-HAMARTOMA-TUMOR-SYNDROME-AHS-M2087-2769C20C06 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Polyposis Syndromes AHS-M2024PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-POLYPOSIS-SYNDROMES-AHS-M2024-32DFC4D44D | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Ophthalmologic Conditions AHS-M2083PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-OPHTHALMOLOGIC-CONDITIONS-AHS-M2083-D47B1CBDF9 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Neurofibromatosis and Related Disorders AHS – M2134PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-NEUROFIBROMATOSIS-AND-RELATED-DISORDERS-C5A32AED8B | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Neurodegenerative Disorders AHS – M2167PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-NEURODEGENERATIVE-DISORDERS-AHS-M2167-D0771C1FC0 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Muscular Dystrophies AHS – M2074PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-MUSCULAR-DYSTROPHIES-AHS-M2074-895ADECB48 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Lipoprotein A Variant(s) as a Decision Aid for Aspirin Treatment and/or CVD Risk Assessment AHS – M2082PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-LIPOPROTEIN-A-VARIANT-S-AS-A-DECISION-AI-E9EF38E43A | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Li-Fraumeni Syndrome AHS – M2081PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-LI-FRAUMENI-SYNDROME-AHS-M2081-7A29215BB7 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Lactase Insufficiency AHS – M2080PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-LACTASE-INSUFFICIENCY-AHS-M2080-7656C93D03 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Inherited Cardiomyopathies and Channelopathies AHS – M2025PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-INHERITED-CARDIOMYOPATHIES-AND-CHANNELOP-E41D00622A | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Hereditary Pancreatitis AHS – M2079PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-HEREDITARY-PANCREATITIS-AHS-M2079-C7D2D6DBE2 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Hereditary Hemochromatosis AHS – M2012PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-HEREDITARY-HEMOCHROMATOSIS-AHS-M2012-E0D45EF21C | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Hereditary Hearing Loss AHS – G2148PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-HEREDITARY-HEARING-LOSS-AHS-G2148-129F80C283 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Germline Variants of the RET Proto-Oncogene AHS - M2078PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-GERMLINE-VARIANTS-OF-THE-RET-PROTO-ONCOG-E603B6AAD2 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for FMR1 Mutations AHS – M2028PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-FMR1-MUTATIONS-AHS-M2028-5FD8C254B0 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Fanconi Anemia AHS – M2077PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-FANCONI-ANEMIA-AHS-M2077-F5C6B48340 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Familial Hypercholesterolemia AHS – M2137PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-FAMILIAL-HYPERCHOLESTEROLEMIA-AHS-M2137-D3998B095D | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Familial Alzheimer’s Disease AHS – M2038PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-FAMILIAL-ALZHEIMERS-DISEASE-AHS-M2038-31AD626E59 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Epilepsy AHS – M2075PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-EPILEPSY-AHS-M2075-DEC739B153 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Diagnosis of Inherited Peripheral Neuropathies AHS – M2072PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-DIAGNOSIS-OF-INHERITED-PERIPHERAL-NEUROP-E3E540C690 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Cystic Fibrosis AHS – M2017PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-CYSTIC-FIBROSIS-AHS-M2017-4A796D318C | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Connective Tissue Disorders AHS - M2144PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-CONNECTIVE-TISSUE-DISORDERS-AHS-M2144-6B7BFD501B | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for CHARGE Syndrome AHS - M2070PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-CHARGE-SYNDROME-AHS-M2070-63ABCA83A9 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Breast, Ovarian, Pancreatic and Prostate Cancers (BRCA) AHS - M2003PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-BREAST-OVARIAN-PANCREATIC-AND-PROSTATE-C-EB1BFE9D54 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing for Alpha- and Beta- Thalassemia AHS - M2131PayerPolicy · BCBSNC-GENETIC-TESTING-FOR-ALPHA-AND-BETA-THALASSEMIA-AHS-M2131-750B9DE4DE | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Testing and Genetic Expression Profiling in Patients with Uveal Melanoma AHS - M2071PayerPolicy · BCBSNC-GENETIC-TESTING-AND-GENETIC-EXPRESSION-PROFILING-IN-PATIENTS-E84276E922 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Genetic Markers for Assessing Risk of Cardiovascular Disease AHS - M2180PayerPolicy · BCBSNC-GENETIC-MARKERS-FOR-ASSESSING-RISK-OF-CARDIOVASCULAR-DISEASE-8259E05E00 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | General Inflammation Testing AHS - G2155PayerPolicy · BCBSNC-GENERAL-INFLAMMATION-TESTING-AHS-G2155-0DB4AC3FA5 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | General Genetic Testing, Somatic Disorders AHS - M2146PayerPolicy · BCBSNC-GENERAL-GENETIC-TESTING-SOMATIC-DISORDERS-AHS-M2146-D6DC233AEB | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | General Genetic Testing, Germline Disorders AHS - M2145PayerPolicy · BCBSNC-GENERAL-GENETIC-TESTING-GERMLINE-DISORDERS-AHS-M2145-3229D312AA | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Gene Expression Profiling and Protein Biomarkers for Prostate Cancer AHS - M2166PayerPolicy · BCBSNC-GENE-EXPRESSION-PROFILING-AND-PROTEIN-BIOMARKERS-FOR-PROSTAT-E498047CD5 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Gamma-glutamyl Transferase Testing in Adults AHS-G2173PayerPolicy · BCBSNC-GAMMA-GLUTAMYL-TRANSFERASE-TESTING-IN-ADULTS-AHS-G2173-A8DCDC8F22 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Folate Testing AHS - G2154PayerPolicy · BCBSNC-FOLATE-TESTING-AHS-G2154-98A8D77871 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Flow Cytometry AHS - F2019PayerPolicy · BCBSNC-FLOW-CYTOMETRY-AHS-F2019-2F0FFFEB42 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Fibromyalgia Testing AHS - M2177PayerPolicy · BCBSNC-FIBROMYALGIA-TESTING-AHS-M2177-1FBEB48DC5 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing AHS - G2060PayerPolicy · BCBSNC-FECAL-ANALYSIS-IN-THE-DIAGNOSIS-OF-INTESTINAL-DYSBIOSIS-AND-207B715248 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Evaluation of Dry Eyes AHS - G2138PayerPolicy · BCBSNC-EVALUATION-OF-DRY-EYES-AHS-G2138-F920F234EF | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Esophageal Pathology Testing AHS - M2171PayerPolicy · BCBSNC-ESOPHAGEAL-PATHOLOGY-TESTING-AHS-M2171-F7C94BA3BD | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Epithelial Cell Cytology in Breast Cancer Risk Assessment AHS - G2059PayerPolicy · BCBSNC-EPITHELIAL-CELL-CYTOLOGY-IN-BREAST-CANCER-RISK-ASSESSMENT-AH-BD105B4231 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Diagnostic Testing of Sexually Transmitted Infections AHS – G2157PayerPolicy · BCBSNC-DIAGNOSTIC-TESTING-OF-SEXUALLY-TRANSMITTED-INFECTIONS-AHS-G2-06FEAFE780 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Diagnostic Testing of Iron Homeostasis and Metabolism AHS - G2011PayerPolicy · BCBSNC-DIAGNOSTIC-TESTING-OF-IRON-HOMEOSTASIS-AND-METABOLISM-AHS-G2-6A3096AA9F | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Diagnostic Testing of Influenza AHS - G2119PayerPolicy · BCBSNC-DIAGNOSTIC-TESTING-OF-INFLUENZA-AHS-G2119-E83F90DD07 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Diagnosis of Vaginitis AHS - M2057PayerPolicy · BCBSNC-DIAGNOSIS-OF-VAGINITIS-AHS-M2057-7DB8DD0045 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Diagnosis of Idiopathic Environmental Intolerance AHS - G2056PayerPolicy · BCBSNC-DIAGNOSIS-OF-IDIOPATHIC-ENVIRONMENTAL-INTOLERANCE-AHS-G2056-193DA992E8 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Diabetes Mellitus Testing - AHS G2006PayerPolicy · BCBSNC-DIABETES-MELLITUS-TESTING-AHS-G2006-0C521E5C81 | New policy |
|---|
| Aug 2, 2026 | Blue Cross NC | Coronavirus Testing in the Outpatient Setting AHS - G2174PayerPolicy · BCBSNC-CORONAVIRUS-TESTING-IN-THE-OUTPATIENT-SETTING-AHS-G2174-A164BE35FA | New policy |
|---|